Elise C Kohn

6PUBLICATIONS
62CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsComputational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 28, 2026
Multi-center Phase 1 study of Triapine in Combination with [177Lu]Lutetium-Dotatate in Patients with Well-Differentiated Neuroendocrine Tumors (ETCTN 10388).

|Mar 05, 2026
Ovarian cancer.

Clare L Scott, Susana Banerjee, Florence Joly

|Apr 07, 2025
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial.

Jung-Min Lee, Austin Miller, Peter G Rose

|Nov 05, 2024
The Diverse Aspects of Uterine Serous Cancer: an NCI workshop on the status of and opportunities for advancement of research.

Naveena B Janakiram, Megan A Clarke, Mihoko Kai

|Oct 14, 2024
Characterization of the Biological Variability of the Angiome Biomarkers over Time in Healthy Participants.

Yingmiao Liu, Jiatong Li, Jing Lyu

|Apr 28, 2022
Biomarker Development: Bedside to Bench.

Grace E Mishkin, Elise C Kohn

Pageof 1